Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Isabel Cristina Valente Duarte de Sousa. (2022) Guidance for the pharmacological management of acne vulgaris. Expert Opinion on Pharmacotherapy 23:1, pages 49-62.
Read now
Read now
Ayşe Öktem, Yıldız Hayran, Esra Arı & Başak Yalçın. (2019) Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris. Journal of Dermatological Treatment 30:8, pages 813-817.
Read now
Read now
Lindsey B. Bauer, Jennifer N. Ornelas, Dirk M. Elston & Ali Alikhan. (2016) Isotretinoin: controversies, facts, and recommendations. Expert Review of Clinical Pharmacology 9:11, pages 1435-1442.
Read now
Read now
Asli Feride Kaptanoglu, Murat Uncu, Selcuk Ozyurt & Evren Hincal. (2013) Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT). Journal of Dermatological Treatment 24:4, pages 272-274.
Read now
Read now
Ilgen Ertam, Sibel Alper & Idil Unal. (2006) Is it necessary to have routine blood tests in patients treated with isotretinoin?. Journal of Dermatological Treatment 17:4, pages 214-216.
Read now
Read now
A Charakida, PE Mouser & AC Chu. (2004) Safety and side effects of the acne drug, oral isotretinoin. Expert Opinion on Drug Safety 3:2, pages 119-129.
Read now
Read now
KF Baxter, TC Ling, JH Barth & WJ Cunliffe. (2003) Retrospective survey of serum lipids in patients receiving more than three courses of isotretinoin. Journal of Dermatological Treatment 14:4, pages 216-218.
Read now
Read now
Articles from other publishers (25)
Andrew Affleck, David Jackson, Hywel C. Williams, Patricia Chavez & Joerg Albrecht. (2022) Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topic. British Journal of Dermatology 187:6, pages 857-865.
Crossref
Crossref
Aneta Teległów, Wioletta Wojtuń, Angelika Żelaszczyk, Bartłomiej Ptaszek, Dorota Godawska & Urszula Rychlik. (2021) Morphological and biochemical evaluation of blood in young women with common acne – preliminary report. Diagnostyka Laboratoryjna 56:3, pages 109-118.
Crossref
Crossref
Megan N. Landis. (2020) Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes. American Journal of Clinical Dermatology 21:3, pages 411-419.
Crossref
Crossref
Mio Nakamura, Sahil Sekhon, Amanda Raymond & John Koo. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology
221
231
.
Tsair-Wei Chien, Yang Shao & Shu-Chun Kuo. (2017) Development of a Microsoft Excel tool for one-parameter Rasch model of continuous items: an application to a safety attitude survey. BMC Medical Research Methodology 17:1.
Crossref
Crossref
D. OpelO.N. Kramer, M. ChevalierM. BigbyJ. Albrecht. (2017) Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis. British Journal of Dermatology 177:4, pages 960-966.
Crossref
Crossref
Guler Bugdayci, Mualla Polat, Hamdi Oguzman & Havva Yasemin Cinpolat. (2016) Interpretation of Biochemical Tests Using the Reference Change Value in Monitoring Adverse Effects of Oral Isotretinoin in 102 Ethnic Turkish Patients. Laboratory Medicine 47:3, pages 213-219.
Crossref
Crossref
Timothy J. Hansen, SaraMarian Lucking, Jeffrey J. Miller, Joslyn S. Kirby, Diane M. Thiboutot & Andrea L. Zaenglein. (2016) Standardized laboratory monitoring with use of isotretinoin in acne. Journal of the American Academy of Dermatology 75:2, pages 323-328.
Crossref
Crossref
Hyunhee Park & Stanley Skopit. (2016) Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne. Dermatologic Clinics 34:2, pages 185-193.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
452
474
.
I. O. Smirnova, Ya. G. Petunova, E. A. Kulikova & A. S. Eremeeva. (2015) Isotretinoin: efficacy and safety (literature review). Klinicheskaya dermatologiya i venerologiya 14:6, pages 20.
Crossref
Crossref
Clio Dessinioti & Christos C. Zouboulis. 2014. Pathogenesis and Treatment of Acne and Rosacea. Pathogenesis and Treatment of Acne and Rosacea
369
375
.
Jessica S. Lilley, MacRae F. Linton & Sergio Fazio. (2013) Oral retinoids and plasma lipids. Dermatologic Therapy 26:5, pages 404-410.
Crossref
Crossref
Shelbi C. Jim On & Joshua Zeichner. (2013) Isotretinoin updates. Dermatologic Therapy 26:5, pages 377-389.
Crossref
Crossref
Elie B. Lowenstein & Eve J. Lowenstein. (2011) Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero. Clinics in Dermatology 29:6, pages 652-661.
Crossref
Crossref
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines
205
317
.
Maria de F?tima de Medeiros Brito, Iara Pessoa Sant'Anna, Juliana Cordeiro Souza Galindo, L?gia Helena Pessoa de Melo Rosendo & Josemir Belo dos Santos. (2010) Avalia??o dos efeitos adversos cl?nicos e altera??es laboratoriais em pacientes com acne vulgar tratados com isotretino?na oral. Anais Brasileiros de Dermatologia 85:3, pages 331-337.
Crossref
Crossref
M.J.D. Goodfield, N.H. Cox, A. Bowser, J.C. McMillan, L.G. Millard, N.B. Simpson & A.D. Ormerod. (2010) Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. British Journal of Dermatology 162:6, pages 1172-1179.
Crossref
Crossref
Carla Aiolfi Guimar?es, Farid Menaa, Bouzid Menaa, Joyce S. Quenca-Guillen, Jivaldo do Rosario Matos, Lucildes Pita Mercuri, Andr? Borges Braz, F?bia Cristina Rossetti, ?rika Rosa Maria Kedor-Hackmann & Maria In?s Rocha Miritello Santoro. (2010) Comparative physical?chemical characterization of encapsulated lipid-based isotretinoin products assessed by particle size distribution and thermal behavior analyses. Thermochimica Acta 505:1-2, pages 73-78.
Crossref
Crossref
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology
1
229
.
. 2009. Meyler's Side Effects of Endocrine and Metabolic Drugs. Meyler's Side Effects of Endocrine and Metabolic Drugs
571
691
.
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
3653
3668
.
Gerd Plewig. 2005. Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie
245
258
.
W.M.C. Mulder & M.M.H.M. Meinardi. 2003.
168
179
.
&NA;. (2001) Isotretinoin is well tolerated in young healthy patients. Reactions Weekly &NA;:860, pages 5.
Crossref
Crossref